Tim Townes, PhD
Disclosures: Supported/contracted research-HemEdits, LLC|Intellectual property rights/patent holder-HemEdits, LLC|Ownership interest (excluding diversified mutual funds)-HemEdits, LLC|Salary/employment-HemEdits, LLC - 02/18/2021

Tim Townes graduated from the University of Tennessee in 1973 with a B.S. degree in Biology.  He completed a M.S. degree in Biology in 1976 and a Ph.D. degree in Microbiology in 1980 from UT. After postdoctoral training in Biochemistry and Molecular Genetics at the University of Cincinnati School of Medicine, Tim accepted a faculty position in August of 1984 at the UAB School of Medicine in the Department of Biochemistry and Molecular Genetics.  He was promoted to Full Professor in 1992 and served as Chairman of the Department of Biochemistry and Molecular Genetics from 2001-2016. He also founded the UAB Stem Cell Institute in 2010.  The major research interest of Dr. Townes’ laboratory presently is the development of genetic therapies for blood disorders such as sickle cell disease and severe combined immunodeficiency. He has published over 90 peer-reviewed papers and has several issued patentsHis most recent work establishes a foundation for the safe and effective correction of inherited and acquired blood disorders.  Dr. Townes is a frequent speaker at international conferences on gene regulation and gene therapy. Recently, he has given invited lectures in Johannesburg, South Africa, San Francisco, California, Washington DC, Boston, Massachusetts and Oxford, England.  In 2017 he founded a biotech company to provide gene correction therapies for sickle cell disease and other blood disorders.  He presently is an Emeritus Professor at the UAB School of Medicine in the Department of Biochemistry and Molecular Genetics and serves as CEO & Chief Scientific Officer of HemEdits, LLC.